Vanguard Group
STJ

Vanguard Group’s St Jude Medical STJ Stock Holding History

Vanguard Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-17,968,368
Closed -$1.44B – 4123
2016
Q4 		$1.44B Buy
17,968,368
+417,903
+2% +$33.2M 0.08% 267
2016
Q3 		$1.4B Buy
17,550,465
+837,031
+5% +$67.6M 0.08% 265
2016
Q2 		$1.3B Buy
16,713,434
+283,777
+2% +$20.2M 0.08% 264
2016
Q1 		$904M Buy
16,429,657
+291,015
+2% +$15.9M 0.06% 385
2015
Q4 		$997M Buy
16,138,642
+411,462
+3% +$26M 0.07% 317
2015
Q3 		$992M Buy
15,727,180
+267,251
+2% +$19.1M 0.07% 295
2015
Q2 		$1.13B Buy
15,459,929
+143,754
+0.9% +$10.4M 0.08% 282
2015
Q1 		$1B Buy
15,316,175
+394,487
+3% +$26.2M 0.07% 326
2014
Q4 		$970M Buy
14,921,688
+586,345
+4% +$37.8M 0.07% 309
2014
Q3 		$862M Buy
14,335,343
+325,417
+2% +$21.3M 0.07% 319
2014
Q2 		$970M Buy
14,009,926
+277,747
+2% +$18M 0.08% 284
2014
Q1 		$898M Sell
13,732,179
-75,106
-0.5% -$4.89M 0.08% 289
2013
Q4 		$855M Buy
13,807,285
+404,631
+3% +$23.4M 0.08% 281
2013
Q3 		$719M Buy
13,402,654
+431,006
+3% +$22.2M 0.07% 304
2013
Q2 		$592M Buy
+12,971,648
New +$562M 0.06% 354

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Vanguard Group's STJ Position: Q1 2017 in Review

Vanguard Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 17,968,368 shares — an estimated $1.44B sold.

Vanguard Group first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $1.44B in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Vanguard Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Vanguard Group sold 17,968,368 St Jude Medical shares in Q1 2017, an estimated $1.44B.
  • Vanguard Group first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Vanguard Group's St Jude Medical position peaked at $1.44B in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Vanguard Group's 13F filing for Q1 2017, filed 12 May 2017.